KEGG: efa:EF0007
STRING: 226185.EF0007
Ribosomal protein S6 (rpsF) is a component of the 30S ribosomal subunit in E. faecalis, which plays crucial roles in translation. The 30S subunit is responsible for recognition and binding of mRNA during translation initiation, decoding information carried by mRNA, and maintaining the reading frame during protein synthesis . While the specific functions of rpsF in E. faecalis haven't been fully characterized, structural analysis suggests it likely contributes to the stability of the 30S subunit and participates in the formation of the decoding center where mRNA codons interact with tRNA anticodons .
The interaction between rpsF and ribosomal RNA (rRNA) in E. faecalis involves specific binding domains that recognize single-stranded regions of 16S rRNA. Based on studies of ribosomal proteins, these interactions typically involve an OB-fold domain that is highly specific for binding single-stranded nucleic acids . Similar to other ribosomal proteins, rpsF likely forms protein-protein interactions with neighboring components of the 30S subunit.
The expression of rpsF in E. faecalis, like many ribosomal proteins, is likely growth phase-dependent, with highest expression during exponential growth when protein synthesis demands are greatest. While specific expression data for rpsF in E. faecalis is limited, studies of the E. faecalis exoproteome have demonstrated that growth conditions significantly influence protein expression patterns .
The regulation of ribosomal protein genes in bacteria often involves feedback mechanisms similar to those observed for protein S1 (bS1) in other bacteria, where the protein can act as an autogenous repressor by binding to its own mRNA . For experimental assessment of rpsF expression patterns, researchers typically employ quantitative PCR or ribosome profiling techniques during different growth phases. Under stress conditions, such as antibiotic exposure or nutrient limitation, expression patterns of ribosomal proteins including rpsF may change as part of the cellular stress response, potentially revealing regulatory mechanisms unique to E. faecalis.
For recombinant production of E. faecalis rpsF, several expression systems can be employed, each with distinct advantages based on research objectives. Bacterial expression systems, particularly E. coli, are most commonly used due to their high yield, rapid growth, and cost-effectiveness . The following table summarizes key expression systems:
| Expression System | Advantages | Limitations | Optimal Applications |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, economical, well-established protocols | Potential misfolding, lack of post-translational modifications | Structural studies, antibody production |
| E. coli Rosetta | Enhanced expression of proteins with rare codons | Higher cost than standard strains | Expression of proteins with rare codon usage |
| E. faecalis homologous | Native folding environment, appropriate post-translational modifications | Lower yield, more complex protocols | Functional studies requiring authentic protein structure |
| Cell-free systems | Rapid production, accommodates toxic proteins | Higher cost, lower yield | Initial screening, proteins toxic to host cells |
For optimal expression, the rpsF gene should be codon-optimized for the host organism and cloned into a vector with an appropriate promoter (such as T7 for E. coli systems). Including a purification tag (His6, GST, or MBP) facilitates downstream purification . Expression conditions must be optimized, with induction typically performed at mid-log phase (OD600 = 0.6-0.8) followed by incubation at 18-25°C to enhance proper folding.
Purification of recombinant E. faecalis rpsF requires a multi-step approach to ensure both high purity and retention of native conformation. A typical purification workflow includes:
Initial capture: Affinity chromatography using the fusion tag (His-tag with IMAC, GST with glutathione resin, or MBP with amylose resin) for selective binding of the target protein.
Tag removal: Cleavage of the fusion tag using a specific protease (TEV, thrombin, or Factor Xa) followed by a second affinity step to remove the cleaved tag.
Polishing steps: Ion exchange chromatography to separate based on charge differences, followed by size exclusion chromatography to remove aggregates and achieve final purity.
For ribosomal proteins that tend to bind RNA, additional steps may be necessary to remove co-purified nucleic acids, such as high-salt washes or treatment with nucleases . Quality control testing should include SDS-PAGE for purity assessment, western blotting for identity confirmation, dynamic light scattering for homogeneity analysis, and circular dichroism to verify proper folding. All recombinant proteins should be tested for identity, purity, and biological activity using appropriate assays to ensure research-grade quality .
Assessing the functionality of purified recombinant E. faecalis rpsF requires multiple complementary approaches:
RNA binding assays: Using electrophoretic mobility shift assays (EMSA) or filter binding assays to evaluate the protein's ability to bind 16S rRNA fragments. The binding affinity and specificity should be compared with those of native rpsF.
Ribosome assembly assays: In vitro reconstitution experiments where recombinant rpsF is added to partial 30S subunits lacking this protein to assess if it restores proper assembly.
Translation activity: Cell-free translation systems can be used to determine if adding the recombinant rpsF to ribosomes with depleted or mutated S6 restores translation efficiency.
Structural integrity assessment: Circular dichroism spectroscopy and thermal shift assays to confirm proper folding and stability of the purified protein.
Complementation studies: Genetic complementation of rpsF-deficient strains to verify if the recombinant protein can restore growth defects associated with rpsF mutations.
For comprehensive functional validation, the recombinant protein should be tested in assays that examine its interaction with both RNA and other ribosomal proteins to confirm its capability to participate in the complex network of interactions within the 30S subunit .
Investigating potential extraribosomal (moonlighting) functions of E. faecalis rpsF requires a multifaceted approach:
Proteomic interaction studies: Using pull-down assays or co-immunoprecipitation followed by mass spectrometry to identify non-ribosomal protein partners. This approach has successfully identified unexpected interactions for other ribosomal proteins .
Localization studies: Fluorescent tagging of rpsF (ensuring the tag doesn't interfere with function) to determine if the protein localizes to non-ribosomal compartments under specific conditions.
Transcriptomic analysis: RNA-seq comparing wild-type and rpsF-depleted strains to identify genes whose expression is affected, potentially revealing regulatory functions.
Phenotypic screens: Creating rpsF mutants with site-specific modifications that maintain ribosomal function but potentially disrupt extraribosomal functions, then screening for phenotypes related to stress response, biofilm formation, or virulence.
Recent studies have shown that bacterial ribosomal proteins can function as autogenous repressors by binding to their own mRNA, similar to the mechanism observed for protein S1 (bS1) . For E. faecalis rpsF, researchers should examine whether it binds to its own mRNA or other regulatory RNAs, particularly under stress conditions, using techniques such as CLIP-seq (cross-linking immunoprecipitation followed by sequencing).
The potential role of rpsF in E. faecalis virulence and antibiotic resistance represents an important research frontier. While direct evidence linking rpsF to these phenomena is limited, several experimental approaches can address this question:
Comparative expression analysis: Quantifying rpsF expression levels in antibiotic-resistant versus susceptible strains and in virulent versus attenuated isolates using qRT-PCR or proteomics.
Mutation studies: Creating rpsF deletion or point mutation strains and assessing changes in minimum inhibitory concentrations (MICs) for various antibiotics, particularly those targeting protein synthesis.
Infection models: Comparing the ability of wild-type and rpsF-modified strains to establish infection in cellular or animal models, with specific focus on adherence, invasion, and persistence.
E. faecalis is a prominent pathogen due to the frequency of disease and its implication in antibiotic resistance transfer . The exoproteome of E. faecalis is known to contain proteins involved in cell wall synthesis and cell division, suggesting potential roles for ribosomal proteins beyond translation . If rpsF is found to interact with proteins in these pathways, it could indicate contributions to cell wall remodeling during antibiotic stress or host-pathogen interactions.
The interaction between rpsF and small RNAs (sRNAs) in E. faecalis may represent an important regulatory mechanism. While specific data on rpsF-sRNA interactions is limited, the Grad-seq technique has been employed to comprehensively predict complexes formed by RNA and proteins in E. faecalis, revealing that some sRNAs are present in the 30S fraction .
To investigate rpsF-sRNA interactions, researchers can employ:
CLIP-seq or RIP-seq: Cross-linking immunoprecipitation or RNA immunoprecipitation followed by sequencing to identify RNAs that directly bind to rpsF in vivo.
In vitro binding assays: Using techniques such as surface plasmon resonance or microscale thermophoresis to characterize binding affinities and kinetics between purified rpsF and candidate sRNAs.
Structural studies: NMR spectroscopy or X-ray crystallography to determine the atomic details of rpsF-RNA complexes.
Some sRNAs found in the 30S fraction of E. faecalis contain potential Shine-Dalgarno sequences and small open reading frames , suggesting they might interact with ribosomes for either regulatory purposes or translation of small peptides. The potential interaction of rpsF with these specific sRNAs could reveal novel regulatory circuits involving both canonical translation functions and non-canonical regulatory mechanisms.
Studying rpsF interactions with the ribosome assembly machinery requires a combination of in vitro and in vivo approaches:
Time-resolved cryo-EM: This technique allows visualization of ribosome assembly intermediates, revealing the timing and structural changes associated with rpsF incorporation into nascent 30S subunits.
FRET (Förster Resonance Energy Transfer): By labeling rpsF and other assembly factors with fluorescent dyes, researchers can monitor real-time interactions during assembly.
Pulse-chase experiments: Using isotope-labeled rpsF to track its incorporation into ribosomes over time, revealing assembly kinetics and potential assembly checkpoints.
In vivo ribosome profiling: This technique can identify ribosome assembly defects in strains with modified rpsF, revealing the protein's role in the assembly process.
Bacterial three-hybrid systems: Modified to detect RNA-protein interactions, this approach can identify specific 16S rRNA regions that interact with rpsF during assembly.
Comparative genomics approaches provide valuable insights into rpsF evolution and conservation:
Phylogenetic analysis: Constructing phylogenetic trees based on rpsF sequences from multiple Enterococcus species and related genera to trace evolutionary relationships and identify selective pressures.
Selection analysis: Calculating dN/dS ratios to determine if rpsF is under purifying, neutral, or positive selection in different bacterial lineages.
Synteny analysis: Examining the genomic context of rpsF across species to identify conserved gene neighborhoods that might indicate functional relationships.
Structure-based sequence alignment: Mapping sequence conservation onto structural models to identify functionally important regions that maintain structural integrity versus regions that may have species-specific functions.
This table summarizes hypothetical conservation data for rpsF across representative species:
| Species | Sequence Identity to E. faecalis rpsF | Conservation Hotspots | Unique Features |
|---|---|---|---|
| E. faecium | 92% | RNA-binding domain, S6 motif | C-terminal extension |
| E. casseliflavus | 88% | Core structure | Modified N-terminus |
| S. aureus | 74% | RNA interaction sites | Different surface charge distribution |
| B. subtilis | 68% | Hydrophobic core | Alternative RNA recognition elements |
| E. coli | 55% | Basic structural elements | Different regulatory elements |
By integrating these approaches, researchers can identify conserved functional domains that are essential for the core functions of rpsF across bacterial species, as well as adaptations that might contribute to species-specific regulatory mechanisms or extraribosomal functions.
Several mass spectrometry (MS) approaches are particularly effective for characterizing post-translational modifications (PTMs) of E. faecalis rpsF:
Bottom-up proteomics: Digesting purified rpsF with proteases like trypsin or chymotrypsin, followed by LC-MS/MS analysis of the resulting peptides to identify modifications such as phosphorylation, methylation, or acetylation.
Top-down proteomics: Analyzing intact rpsF to preserve the relationship between multiple PTMs on the same protein molecule, providing a comprehensive view of proteoforms.
Middle-down proteomics: Using limited proteolysis to generate larger peptide fragments that retain information about co-occurring modifications.
Targeted MS approaches: Using parallel reaction monitoring (PRM) or selected reaction monitoring (SRM) to focus on specific modified peptides of interest with higher sensitivity.
Crosslinking MS: Employing chemical crosslinkers followed by MS to identify interaction partners of rpsF in its modified states.
For comprehensive PTM mapping, researchers should combine enrichment strategies (such as phosphopeptide enrichment using titanium dioxide or IMAC) with high-resolution mass spectrometry. Analysis should include comparison of PTMs under different growth conditions and stress responses, as ribosomal protein modifications often change in response to environmental cues. This approach has been successfully used to characterize proteins in the E. faecalis exoproteome, revealing multiple mass and pI variants of proteins .
Studying E. faecalis rpsF function in vivo presents several technical challenges:
Essential gene manipulation: As a ribosomal protein, rpsF is likely essential, making traditional knockout approaches challenging. Researchers should consider:
Conditional expression systems (tetracycline-inducible or similar)
CRISPR interference (CRISPRi) for partial knockdown
Temperature-sensitive mutants
Domain-specific mutations that affect specific functions while maintaining viability
Distinguishing ribosomal from extraribosomal functions: Since rpsF is primarily associated with ribosomes, separating its direct effects from translation-dependent effects requires careful experimental design:
Specific mutations that affect potential extraribosomal functions without disrupting ribosome assembly
Ribosome profiling to distinguish direct effects on translation from secondary effects
Temporal analysis of consequences following rpsF depletion
Genetic manipulation in a clinical pathogen: E. faecalis presents challenges for genetic manipulation due to:
Protein-specific antibodies: Developing highly specific antibodies against E. faecalis rpsF can be challenging due to potential cross-reactivity with other ribosomal proteins or homologs in related species. Epitope mapping and extensive validation are essential to ensure specificity for immunological studies.
The potential role of rpsF in stress adaptation represents an important research frontier:
Transcriptional and translational regulation during stress: During stress conditions, bacteria often modulate translation machinery. Researchers should investigate:
Changes in rpsF expression levels under various stresses (oxidative, acid, antibiotic, temperature)
Post-translational modifications of rpsF in response to stress
Association of rpsF with stress-specific mRNAs or regulatory RNAs
Potential protein moonlighting functions: Many ribosomal proteins perform secondary functions during stress. Possible approaches include:
Analyzing phenotypes of rpsF mutants under specific stress conditions
Identifying stress-specific protein interaction partners
Examining potential DNA/RNA binding activities outside the ribosome
Coordination with stress response pathways: Investigating how rpsF might interact with established stress response pathways such as the fsrABDC system, which is known to regulate the composition of the E. faecalis exoproteome .
The exoproteome of E. faecalis fsrB mutants is characterized by general stress and glycolytic proteins , suggesting a connection between regulatory systems and stress responses. If rpsF expression or modification patterns correlate with these changes, it might indicate a role in coordinating translational responses to stress conditions.
The essential nature of ribosomal proteins makes them potential targets for antimicrobial development. Several approaches could exploit rpsF for therapeutic purposes:
Structure-based drug design: Using high-resolution structural data of E. faecalis rpsF to:
Design small molecules that interfere with rpsF incorporation into the ribosome
Target E. faecalis-specific features of rpsF that differ from human ribosomal proteins
Develop peptide mimetics that disrupt specific rpsF interactions
RNA-protein interaction inhibitors: Designing compounds that:
Block specific interactions between rpsF and 16S rRNA
Interfere with potential regulatory interactions between rpsF and mRNA or sRNAs
Disrupt assembly pathways dependent on rpsF
Targeting potential extraribosomal functions: If moonlighting functions of rpsF contribute to virulence or stress adaptation, these might offer selective therapeutic targets that:
Disrupt biofilm formation
Sensitize bacteria to existing antibiotics
Interfere with host-pathogen interactions
Immunotherapeutic approaches: If rpsF has exposed epitopes or is released during infection:
Development of antibodies that bind to surface-exposed portions of rpsF
Design of vaccines targeting rpsF epitopes that are conserved across enterococcal strains
Creation of immunomodulatory therapies that enhance host recognition of rpsF
E. faecalis is prominent among pathogens due to the frequency of disease and its implication in antibiotic resistance transfer . Novel therapeutic approaches targeting essential machinery like rpsF could provide alternatives to conventional antibiotics in the face of increasing resistance.